George Coukos, Director of Oncology University Hospital of Lausanne & Branch Director at Ludwig Cancer Research, shared a post by Society for Immunotherapy of Cancer (SITC), adding:
“Deeply honored to have been recognized with this exceptional distinction. Humbled by joining such esteemed colleagues.“
Quoting Society for Immunotherapy of Cancer‘s post:
“We are pleased to announce the 2025 class of Fellows of the Academy of Immuno-Oncology (FAIO). The Academy recognizes individuals who have launched the field of cancer immunotherapy into the breakthrough treatment it is today. Learn about the 2025 class:”